"10.1371_journal.pone.0062149","plos one","2013-05-01T00:00:00Z","Iana H Haralambieva; Ann L Oberg; Inna G Ovsyannikova; Richard B Kennedy; Diane E Grill; Sumit Middha; Brian M Bot; Vivian W Wang; David I Smith; Robert M Jacobson; Gregory A Poland","Vaccine Research Group, Mayo Clinic, Rochester, Minnesota, United States of America; Program in Translational Immunovirology and Biodefense, Mayo Clinic, Rochester, Minnesota, United States of America; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, United States of America; Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, United States of America; Sage Bionetworks, Seattle, Washington, United States of America; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America","Conceived and designed the experiments: IHH ALO IGO RBK DEG DIS RMJ GAP. Performed the experiments: IHH IGO RBK. Analyzed the data: IHH ALO RBK DEG SM BMB VWW DIS GAP. Wrote the paper: IHH ALO IGO RBK DEG SM BMB VWW DIS RMJ GAP.","Dr. GAP is the chair of a Safety Evaluation Committee for investigational vaccine trials being conducted by Merck Research Laboratories. Dr. GAP offers consultative advice on vaccine development to Merck & Co. Inc., CSL Biotherapies, Avianax, Sanofi Pasteur, Dynavax, Novartis Vaccines and Therapeutics, and PAXVAX Inc. Dr. RMJ is a member of a Data Monitoring Committee for two Merck vaccine studies as well as a Safety Review Committee for another Merck vaccine study. He also recently served as a principal investigator for three vaccine studies including one by Novartis and two by Pfizer. BMB is employed by Sage Bionetworks, which is a commercial company. This does not alter the authors adherence to all PLOS ONE policies on sharing data and materials.","2013","05","Iana H Haralambieva","IHH",11,TRUE,8,3,9,11,TRUE,TRUE,FALSE,0,NA,FALSE
